Prihlásiť sa Zaregistrujte sa zadarmo

Inštitucionálne vlastníctvo spoločnosti Alexion Pharmaceuticals

Aká je hodnota metriky Inštitucionálne vlastníctvo spoločnosti Alexion Pharmaceuticals?

Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Alexion Pharmaceuticals Inc. je 88.27%

Aká je definícia metriky Inštitucionálne vlastníctvo?



Inštitucionálne vlastníctvo (Institutional Ownership) je množstvo akcií spoločnosti vlastených podielovými alebo penzijnými fondami, poisťovňami, investičnými firmami, a ďalšími entitami, ktoré spravujú peňažné prostriedky iných.

Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.

Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.

Inštitucionálne vlastníctvo spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Alexion Pharmaceuticals

Čomu sa venuje spoločnosť Alexion Pharmaceuticals?

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology and acute care. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries.

Firmy s metrikou inštitucionálne vlastníctvo podobnou spoločnosti Alexion Pharmaceuticals



  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Turning Point Brands Inc je 88.21%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Vy Global Growth je 88.22%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Tailored Brands je 88.24%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Tailored Brands je 88.24%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Pinnacle Partners je 88.24%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Crescent Acquisition je 88.25%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Alexion Pharmaceuticals je 88.27%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Analog Devices je 88.27%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Analog Devices je 88.27%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Analog Devices je 88.27%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Qurate Retail Inc je 88.30%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti St. Joe Co je 88.30%
  • Hodnota metriky Inštitucionálne vlastníctvo spoločnosti Herman Miller je 88.30%